Pharmosa Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,750	974.06	672.51	461.46	414.54
Cash & Short-Term Investments	1,750	974.06	672.51	461.46	414.54
Cash Growth	218.12%	44.84%	45.74%	11.32%	-
Other Receivables	6.07	1.47	0.29	0.31	0.15
Receivables	6.07	1.47	0.29	0.31	0.15
Inventory	36.04	21.91	-	-	-
Prepaid Expenses	23.45	12.67	11.65	14.18	8.69
Other Current Assets	-	-	-	0.02	4
Total Current Assets	1,815	1,010	684.45	475.96	427.37
Property, Plant & Equipment	235.77	180.61	30.12	33.44	40.86
Long-Term Investments	73.02	71.22	65.69	61.6	60.91
Other Intangible Assets	0.1	0.09	0.15	0.18	-
Other Long-Term Assets	92.75	71.62	18.95	15.19	14.13
Total Assets	2,217	1,334	799.37	586.37	543.27
Accounts Payable	0.36	0.59	-	-	-
Accrued Expenses	27.4	33.24	12.28	11.66	10.43
Short-Term Debt	-	-	-	-	61
Current Portion of Long-Term Debt	-	1.26	3.52	8.43	18.81
Current Portion of Leases	17.68	24.69	7.19	6.8	6.43
Other Current Liabilities	37.45	17.8	4.77	6.19	2.58
Total Current Liabilities	111.45	77.58	27.77	33.07	99.25
Long-Term Debt	-	1.19	2.45	5.96	14.83
Long-Term Leases	108.69	117.23	8.04	15.9	23.36
Total Liabilities	225.1	195.99	38.25	54.93	137.44
Common Stock	645.09	586.02	554.67	489.24	402.5
Additional Paid-In Capital	1,438	531.34	1,180	-	454.19
Retained Earnings	-91.25	20.28	-973.44	-706.94	-450.46
Comprensive Income & Other	0.01	0.01	0.01	749.13	-0.41
Shareholders' Equity	1,992	1,138	761.12	531.44	405.83
Total Liabilities & Equity	2,217	1,334	799.37	586.37	543.27
Total Debt	126.37	144.37	21.19	37.09	124.43
Net Cash (Debt)	1,623	829.69	651.32	424.37	290.1
Net Cash Growth	246.74%	27.39%	53.48%	46.28%	-
Net Cash Per Share	13.55	7.32	6.61	5.00	6.09
Filing Date Shares Outstanding	129.02	117.2	110.93	97.85	49.99
Total Common Shares Outstanding	129.02	117.2	110.93	97.85	49.99
Working Capital	1,704	932.53	656.68	442.89	328.12
Book Value Per Share	15.44	9.71	6.86	5.43	8.12
Tangible Book Value	1,992	1,138	760.97	531.25	405.83
Tangible Book Value Per Share	15.44	9.71	6.86	5.43	8.12
Machinery	55.52	27.11	26.37	17.05	19.59
Construction In Progress	49.52	35.61	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.